Lilly says antibody drug cuts COVID-19 risk for nursing home residents
A trial of Eli Lilly's antibody drug shows it can reduce the risk of COVID-19 by 80% for nursing home residents, the company said on Thursday, although the need for such disease prevention tools has dwindled as vaccines become available. This report produced by Jillian Kitchener.
UP NEXT
NOW PLAYING: lifestylegeneral
Lilly says antibody drug cuts COVID-19 risk for nursing home residents
Reuters
UP NEXT
-
Obesity a driving factor in COVID-19 deaths, global report finds
Reuters
-
Germany to ease COVID-19 curbs, ramp up vaccinations
-
Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
-
Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
-
New U.S. COVID-19 cases hit plateau after steep drops
-
Global COVID-19 infections up for first time in seven weeks, WHO says
-
U.S. downplays possibility of sharing COVID-19 vaccines with Mexico
-
J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators
-
More than 20 million in Britain get first COVID-19 vaccine dose
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
-
Exclusive: Mexico's president expected to ask Biden to share U.S. vaccines, say sources
-
"Things are tenuous," U.S. CDC says as downward trend in COVID-19 cases stalls
-
UK to prioritise next stage of COVID-19 vaccines by age, not job
-
Advisory panel says FDA should authorize Johnson & Johnson COVID-19 vaccine
-
FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A0E918589868C63F102918A79879E62C3%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%279d4233e1-13e3-481f-8e98-907099e8b2ca%27&-ver=%271.0%27&-impressionGuid=%279d4233e1-13e3-481f-8e98-907099e8b2ca%27&-pageName=%27channelplayerpage%27&-uri=%27https%253A%252F%252Fwww.msn.com%252Fen-au%252Flifestyle%252Flifestylegeneral%252Flilly-says-antibody-drug-cuts-covid-19-risk-for-nursing-home-residents%252Fvp-BB1cYvnM%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"video"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"9d4233e113e3481f8e98907099e8b2ca"%2C"clid"%3A"0E918589868C63F102918A79879E62C3"%2C"clidType"%3A"muid"%2C"di"%3A"19552"%2C"partner"%3A"Reuters"%2C"publcat"%3A"Reuters%2BNews%2B%2526%2BMedia%2BInc."%2C"cvs"%3A"Browser"%2C"subcvs"%3A"lifestyle"%2C"entityId"%3A"BB1cYvnM"%2C"entitySrc"%3A"vp"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"lifestylegeneral"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-au%27){kind=small}